Patent details

Basic Information

Publication number:

EP1307225

PCT Application Number:

PCT/US/2001/024783

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP019596287

PCT Publication Number:

WO/2002/011767

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTAGONISTS OF CD30 OR CD30L FOR USE IN TREATING AUTO-IMMUNE AND CHRONIC INFLAMMATORY CONDITIONS

French Title of Invention:

ANTAGONISTES DE CD30 OU CD30L POUR DE TRAITEMENT DES TROUBLES INFLAMMATOIRES AUTO-IMMUNS ET CHRONIQUES

German Title of Invention:

CD30 ODER CD30L ANTAGONISTEN ZUR BEHANDLUNG VON AUTOIMMUN UND KRONISCH ENTZÜNDLICHEN ZUSTÄNDEN

SPC Number:

Dates

Filing date:

06/08/2001

Grant date:

26/05/2010

EP Publication Date:

26/05/2010

PCT Publication Date:

14/02/2002

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

07/05/2003

EP B1 Publication Date:

26/05/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/08/2010

Expiration date:

06/08/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

06/08/2001

 

 

Name:

Immunex Corporation

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Inventor

1

Name:

BARONE Dauphine, S.

Address:

United States (US)

2

Name:

PLUENNEKE John, D.

Address:

United States (US)

3

Name:

KENNEDY Mary, K.

Address:

United States (US)

4

Name:

PESCHON Jacques, J.

Address:

United States (US)

5

Name:

MOHLER Kendall, M.

Address:

United States (US)

Priority

Priority Number:

224079 P

Priority Date:

08/08/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 39/395;

Filing date	Document type	Number of pages